Deal Announcements

Zafgen Garners Series B Venture Capital Funding

Wednesday, March 03, 2010 5:49:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts  --  Biotechnology company Zafgen has landed $8.1 million for its second round of venture capital financing.

Zafgen says that it is developing innovative therapeutics for the treatment of obesity.

Investors in the round included Third Rock Ventures and Atlas Venture.  Proceeds purposes from the financing round were not disclosed by the company.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1